Sign in to follow
Search Results

0 results for 'Sanofi SA'

You can use to get even better search results
June 21, 2004 |

Dickstein Shapiro Morin & Oshinsky

3 minute read
September 25, 2006 |

Icahn's Influence Could Dictate ImClone's Decision to Appeal Patent Ruling

Carl Icahn isn't getting his way, at least not yet. ImClone Systems responded to its most famous shareholder's latest attacks by giving him a board seat but keeping Chairman David Kies, despite Icahn's continued public thrashing of him. One indication of Icahn's influence could come in the legal battle over a key patent behind ImClone's sole marketed product, cancer fighter Erbitux. If ImClone reverses course and drops its appeal of the patent case, it would be a concession to one of Icahn's public demands.
4 minute read
January 25, 2013 |

Unapproved Opinions

Opinions not approved for publication.
49 minute read
April 19, 2004 |

Vitamin Fight Could Energize Foreign Suits

Vitamin sellers and foreign buyers are playing for multibillion-dollar stakes in a Supreme Court case to be argued April 26. Thomas Goldstein, who will represent the buyers, says the case could answer key questions about the international application of U.S. antitrust law.
9 minute read
April 11, 2011 |

CVS $25 billion benefit looms with Caremark breakup: real M&A

CVS Caremark Corp., created in a takeover four years ago that has left investors with underperforming stock, could be worth $25 billion more if the company split itself up.
6 minute read
April 08, 2011 |

CVS $25 billion benefit looms as SunAmerica agitates for breakup

CVS Caremark Corp. (CVS), created in a takeover four years ago that has left investors with underperforming stock, could be worth $25 billion more if the company split itself up.
6 minute read
May 17, 2000 |

The Yanks Have Come

As little as three years ago, law firms were scaling back their European operations. Now, an upturn in European M&A activity, the increasing importance of the European Commission's merger approval power, and the emergence of Internet business in Europe can all be credited for a boom in European deal, regulatory, and legislative work at many U.S.-based firms. Yanks are responding, opening outposts in major Euro hubs, such as London and Brussels.
9 minute read
March 03, 2009 |

Pfizer-Wyeth deal boosts slumping M&As

Pfizer delivered the depressed mergers and acquisitions market some potent medicine as 2009 dawned. In January, the New York-based pharmaceutical giant, looking to replace revenue sapped by increased competition from generic drugs, agreed to buy Wyeth of Madison, N.J., for $68 billion, in the biggest pharma deal since 2004.
5 minute read
January 01, 2011 |

The French Empires

Gide and Salans both started in Paris and spread around the globe. But please, no comparisons.
14 minute read
October 05, 2009 |

Ex-U.S. attorney leads BofA chief's defense

4 minute read

TRENDING STORIES

    More from ALM

    More from ALM

    Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

    Resources

    • Revenue, Profit, Cash: Managing Law Firms for Success

      Brought to you by Juris Ledger

      Download Now

    • Law Firm Operational Considerations for the Corporate Transparency Act

      Brought to you by Wolters Kluwer

      Download Now

    • The Ultimate Guide to Remote Legal Work

      Brought to you by Filevine

      Download Now

    • Practical Guidance Journal: Protecting Work Product in a Generative AI World

      Brought to you by LexisNexis®

      Download Now